key: cord-0918349-qqflhrhi authors: Hassanein, Mohamed; Hussein, Zanariah; Shaltout, Inass; Juani Wan Seman, Wan; Chin Voon, Tong; Mohd Noor, Nurain; Akif Buyukbese, Mehmet; El Tony, Lobna; Mohamed Shaker, Gamal; Alamoudi, Reem M.; Hafidh, Khadija; Fariduddin, M.; Batais, Mohammed A.; Shaikh, Shehla; Rachid Malek, Pr; Alabbood, Majid; Sahay, Rakesh; Alshenqete, Abdulwadod M.; Yakoob Ahmedani, Muhammad title: The DAR 2020 Global survey : Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes date: 2021-01-23 journal: Diabetes Res Clin Pract DOI: 10.1016/j.diabres.2021.108674 sha: 5404d6e2393efc5042dd0920d2e268e7bad647c2 doc_id: 918349 cord_uid: qqflhrhi Objectives The DAR Global surveyof Ramadan-fasting during the COVID-19 pandemic aimed to describe the characteristics and care in participants with type 2 diabetes (T2D)with a specific comparison between those < 65years and>65 years. Methods Participantswere consented to answer aphysician-administered questionnairefollowing Ramadan 2020. Impact of COVID-19 on the decision of fasting,intentions to fast and duration of Ramadan and Shawalfasting, hypoglycaemia and hyperglycaemia eventswere assessed. Specific analysis comparing age categories of <65 years and>65years were performed. Results Among the 5865 participants, 22.5% were>65 years old. Concern for COVID-19 affected fasting decisionfor 7.6% (> 65years) vs 5.4% (<65years). More participants >65 years old did not fast (28.8% vs 12.7%,<65 years). Of the 83.6%, participantsfulfillingRamadan-fasting, 94.8%fasted >15 days and 12.6% had to break fast due to diabetes-related illness.The average number of days fasting within and post-Ramadan were 27 and 6 days respectively, regardless of age. Hypoglycaemia and hyperglycaemia occurred in 15.7% and 16.3% of participants respectively,with 6.5% and 7.4% requiringhospital care respectively. SMBGwas performed in 73.8% of participants and 43.5% received Ramadan-focused education. Conclusion During the COVID-19 pandemic, universally high rates of Ramadan-fasting were observedregardless of fasting risk level.Glycemic complications occurred frequently witholder adults requiring higher rates of acute hospital care. Risk stratification is essential followed bypre-Ramadan interventions, Ramadan-focused diabetes education and self-monitoringto reduce and prevent complications, with particular emphasis in older adults. The DAR Global survey of Ramadan-fasting during the COVID-19 pandemic aimed to describe the characteristics and care in participants with type 2 diabetes (T2D) with a specific comparison between those < 65years and > 65 years. Participants were consented to answer a physician-administered questionnaire following Ramadan 2020. Impact of COVID-19 on the decision of fasting, intentions to fast and duration of Ramadan and Shawal fasting, hypoglycaemia and hyperglycaemia events were assessed. Specific analysis comparing age categories of <65 years and > 65years were performed. Among the 5865 participants, 22.5% were > 65 years old. Concern for COVID-19 affected fasting decision for 7.6% ( > 65years) vs 5.4% (<65years). More participants > 65 years old did not fast (28.8% vs 12.7%, <65 years). Of the 83.6%, participants fulfilling Ramadan-fasting, 94.8% fasted > 15 days and 12.6% had to break fast due to diabetes-related illness. The average The number of Muslims around the world is projected to be 1.9 billion in 2020, which is 24.9% Fasting may increase the risk of complications such as acute glycaemic events; hypoglycemia, hyperglycemia and diabetic ketoacidosis as well as dehydration, and thrombosis (5) , which may be exacerbated by concurrent COVID-19 infection. Well established guidelines have recommended that physicians perform risk stratification of patients intending to fast during Ramadan based on status of glycaemic control, hypoglycaemia risk, glycaemic lowering medications, diabetes related complications and comorbidities. Individuals in the high and very high risk categories for developing complications related to fasting should be advised against fasting (3, 4, 6) . The high rates of fasting observed in previous multi-national and regional studies indicate that many patients who are considered to be at high or very high risk of adverse events still fast during Ramadan (5, 7, 8) During Ramadan, there may be a temporary change in lifestyle practices which may differ according to geographical regions and countries. The EPIDIAR study reported that approximately 50% of participants with diabetes experienced a change in lifestyle and adjustments in diabetes-related treatments (5) . The study highlighted the various challenges for people with diabetes who fast during Ramadan and the need to improve their diabetes management, by providing pre-Ramadan structured patient education along with specific management guidelines for health care providers. Several guidelines and recommendations for the management of diabetes during Ramadan have been developed along with educational programs (4, 9) . Ramadan-focused education can enable individuals to adjust their lifestyle during Ramadan to minimise the risk of complications (10, 11) . The DAR-MENA T2DM study conducted during Ramadan 2016 in the Middle East and North African region reported that 97.4% of participants performed lifestyle changes during Ramadan with more than half (60.6%) having had access to education on diabetes management during Ramadan (8) . To date, there has been no published data to specifically characterize Ramadan fasting among older adults with diabetes. This is an area of specific concern as older adults have higher rates of diabetes-related complications and co-morbidities, longer duration of disease and higher risk to develop the specific complications known to occur during Ramadan fasting such as hypoglycaemia, hyperglycaemia, dehydration and thrombosis. This cross-sectional, observational survey currently represents the largest recent multinational epidemiological analysis of Ramadan fasting among T2D almost two decades after the EPIDIAR study in 2001 and a decade after the CREED study in 2010. It will enable us to better understand the current fasting practices among individuals with T2D living in the different geographical regions of Asia, Gulf and Middle East, North Africa and Europe and assess the impact of Ramadan-focused management guidelines and education initiatives, as well as newer glycaemic-lowering therapies towards improving safety outcomes of Ramadan fasting particularly hypoglycaemia and hyperglycaemia events. The additional analysis according to age categories will further allow us to appreciate similarities and differences among individuals <65 years and those >65 years to indicate specific management issues and guide specific lifestyle and treatment recommendations in older individuals with T2D who fast during Ramadan. The primary objective of this survey is to describe the characteristics and patterns of care of people with T2D fasting during and after Ramadan 2020 amidst the COVID-19 global pandemic, with a specific comparison between those <65years and >65 years. A total of 20 countries with a predominant Muslim population participated in this crosssectional survey to assess fasting practices among people with T2D during Ramadan 2020 (23 rd North Africa (Algeria, Cote d'Ivoire, Morocco, Sudan, Tunisia) and Europe (Turkey and United Kingdom). In each country, Muslim people with diabetes were invited to participate in the survey during their routine clinic consultation in the 10-week post-Ramadan period, between June and August 2020. These included those being managed in both community-based and hospital-based diabetes care. Healthcare professionals that included primary care physicians, physicians and endocrinologists that represented different levels of diabetes care in each country were selected to participate in this study. The inclusion criteria were Muslim adults with a known diagnosis of diabetes, attending their routine diabetes clinic consultation and able to provide informed consent. Participating physicians from each country were familiarized and trained on the study questionnaire and administration by their respective country chief investigators. During the routine clinic consultation, the attending physician conducted a guided interview based on a questionnaire about their disease status and management, fasting practices during and following Ramadan 2020. The survey included questions to determine (i) intention to fast during Ramadan: number of fasting days, occurrence and reasons of breaking fast during Ramadan (ii) whether the COVID-19 pandemic influenced decisions to fast, (iii) occurrence of complications of hypoglycemia and hyperglycemia during Ramadan fasting and their related details such as frequency, timing, duration and need for attendance to emergency department (ED) and hospital admission, (iv) level of Ramadan-focused diabetes education and SMBG practices during Ramadan. Hypoglycaemia was reported based on presence of typical symptoms and hyperglycaemia was defined as blood glucose >300mg/L(16.6 mmol/l). Questions regarding physical activity and dietary practices were not specifically addressed in this survey. Information regarding disease status such as duration of disease, presence of diabetes-related complications and co-morbidities, status of glycaemic control and current diabetes-related medications were provided by their attending doctors from the patient's records. Specific risk categorization for Ramadan fasting usually performed at pre-Ramadan assessment was not assessed as the survey was administered post-Ramadan. Responses were recorded either directly into an online questionnaire during the interview or transcribed subsequently from paper-based questionnaire onto the online platform. The survey had the approval of the local research and ethics authorities in each participating country, in accordance with local regulations in each country. Data were stratified by the overall participants of T2D and age categories of <65 years and >65 years. Descriptive analyses were performed to characterize patient demographic and clinical characteristics and all outcome measures. The data are presented as mean and standard deviations (SD) for continuous variables unless mentioned otherwise. Descriptive categorical data were summarized by number and percentage of the population. The proportion of participants experiencing hypoglycaemia and hyperglycaemia or any categorical variable were described in terms of their frequency and percentage for each event (the basis of percentage being the number of participants who provided data). Not all data were available for all measurements and, therefore, total n values differ between measurements. Missing data were not imputed. Differences in demographic characteristics and clinical outcomes between participants aged <65 years and >65 years were tested using Pearson Chi-Squared test for categorical variables. All applied statistical tests were two-sided, p-values <0.05 were considered as statistically significant. The data were analysed using IBM SPSS Statistics Version 26. A total of 5865 people with T2D agreed to participate in the survey with 51.0% female participants and 22.5% aged >65 years. The countries with the highest numbers of participants were Pakistan(15.9%), Egypt(14.0%), KSA(13.1%) and Malaysia(12.8%) as seen in Supplement. South Asia region had the highest rate of participants (26.3%) followed by Gulf region(19.1%), Middle East region(18.8%), South East Asia(16.1%), North Africa(11.2%) and Europe(8.2%). (Supplement Table 1a , Figure 1 ) There were few notable differences in characteristics of participants aged <65 years, compared to those aged >65years as seen in Table 2 . The mean age of participants was 55.1 ± 11.83 years with a mean diabetes duration of 10.5 ± 7.66 years and more than half (50.7%) of those <65 years had diabetes for less than a decade whereas one third (33.6%) of those >65 years had disease for 20 years and more. With respect to risk stratification based on guidelines (4,6), fewer participants aged >65 years had HbA1c > 9.0%, 28.5% (N=325) vs 33.4% (N=1362) in <65 years age category. On the other hand, it was well evident that complications such as macrovascular disease and nephropathy, both indicating high and very high risk categories, were more frequent in those aged >65 years as seen in Table 1 . There were lower rates of use of Metformin, SGLT-2 inhibitors and GLP1-receptor agonists in participants >65 years compared to <65yrs. Insulin use was higher in participants aged >65 years (53.1%) compared to those < 65 years (42.7%). 9.1% for prandial insulin and 32.7% for pre-mixed insulin. Of the overall participants, 4906 (83.6%) intended to fast with no gender difference in the rates of fasting ( days. Concern for the ongoing Covid-19 pandemic did not influence the decision to fast in 91.5% of the overall survey participants, however significantly more participants >65 years agreed that it affected their decision to fast, 7.6% vs 5.4% of those < 65 years (P=0.006). (Table 2) . Breaking of fast due to diabetes-related illness occurred in 12.5% (n = 613) of the overall survey participants who performed Ramadan fasting, with a significantly higher proportion among those >65 years, 17.0% vs 11.5% in < 65 years (P = 0.000). Among those with a break of fast due to diabetes-related illness, almost three quarters (71.9%) was for a short duration of Supplement Table 2a . The percentage of participants who performed SMBG was 73.8% (n=4287). Majority of the participants performed SMBG at the same frequency as before Ramadan. Majority of participants performed SMBG less than once weekly (23.6%), followed by twice daily (19.6%), 2-4 times weekly (17.5%), once weekly (16%), once daily (14.6%) and 3-4 times daily (8.8%). The same pattern was also seen in those participants <65 years and >65 years. There was no significant difference in pattern of SMBG in these 2 groups (P>0.05). (Supplement Figure 3) Only Despite advice and recommendations from their treating physicians, many individuals will insist and decide to perform Ramadan fasting regardless of their risk category. It is important that their treating physicians are able to perform a pre-Ramadan medical review, administer appropriate Ramadan-focused diabetes education and institute treatment adjustments to enable safe fasting during Ramadan for these individuals at elevated risk (3,4). In our study which was carried out post Ramadan, specific risk categorization was not performed, as usually assessed in pre-Ramadan medical review. In this study, participants with T2D were mostly on combinations of oral glucose lowering An important component of the Ramadan focused diabetes education is to impart awareness and knowledge to individuals with diabetes regards safe fasting and when to consider breaking the fast due to medical reasons related to diabetes such as hypoglycaemia, hyperglycaemia and dehydration (3, 4, 9) . In this study, 1 in 8 participants who fasted during Ramadan experienced a break in fasting, being more common in those >65 years (1in 5) compared to those <65 years (1in 9). This is expected as those individuals who are older are at a greater risk of adverse outcomes related to complications and have been advised accordingly by their healthcare providers to have a lower threshold to break their fast to prevent acute and serious complications. With regards to voluntary fasting during the month of Shawal, more than a quarter (26.1%) participants in this study performed this practice which is comparable to the CREED study which reported that 30% of patients fasted outside of Ramadan. Interestingly the mean number of days of Shawal fasting in this study was 6 days which is the preferred duration recommended, following in the footsteps of the Prophet Muhammad (Peace be Upon Him). Fasting six days in Shawal is very special as it completes the fast in Ramadan and educates Muslim individuals to have high self-discipline and perseverance (17) . Hypoglycemia is an important complication to be evaluated during Ramadan. In the previous landmark study, EPIDIAR, the frequency of admission for severe hypoglycemia among participants with T2D was 9% (5). In CREED, the incidence of patient-reported hypoglycemia was 8.8% (7) whereas the DAR-MENA T2DM study reported a 10.4% incidence of confirmed hypoglycemia during Ramadan (8) . In our study, a higher rate of hypoglycemia, 15.6% was reported, based on symptoms. This higher rate could be due to the different definitions used compared to previous studies. Overall, one in fifteen (6.6%) participants with hypoglycemia required either ED care or hospital admission. The majority of participants with hypoglycaemia were able to self-treat at home probably reflecting the lesser severity of hypoglycaemia experienced as well as the improved awareness, knowledge and ability for self-management. On the other hand, the relatively low attendance for hospital care related to hypoglycaemia can also be explained by avoidance of ED visits due to fear of COVID-19 infection (18) . Comparatively, it is important to highlight that one in ten (12.4%) participants aged ≥65 years with hypoglycemia reported requiring ED care or hospitalization suggesting that they may have experienced more severe episodes. Older age is a known risk factor for hypoglycemia (20) . The findings of higher proportion of hypoglycemia among our participants aged ≥65 years is an important reminder to take in account age when assessing a patient's risk for fasting during Ramadan. Not surprisingly, hypoglycaemia was more frequent towards the end of the fast. More emphasis should be given to monitoring at this time of the day. A rather alarming finding from this study was participants' actions in response to hypoglycaemia. A quarter of participants did not take any additional action following an episode of hypoglycaemia. There was a small proportion of patients who experienced hypoglycaemia every day during Ramadan. Improving hypoglycemia awareness and knowledge would enhance safety of fasting among individuals with T2D. Future area of research could include creation of a risk calculator for assessment of suitability to fast which takes into account specific age categories, use of insulin and insulin secretagogues, presence of diabetes-related complications as well as hypoglycemia knowledge. In this survey, the proportion of participants with T2D experiencing hyperglycaemia during Ramadan was 16.3%. In the DAR-MENA T2DM study, the reported incidence of hyperglycaemia was 11.6% (8) . The EPIDIAR study revealed that 4% of T2D participants experienced hyperglycaemia requiring hospitalisation, with an increase in the rate of hospitalisation from 1 to 5 events/100 people/month, comparing prior and during Ramadan (5) . In this study, 7.4% (1 in 13) of participants who experienced hyperglycaemia required either ED care or hospital admission and a higher rate (8.4%) was seen in participants aged > 65 years. This can be an underestimation due to fear of exposure to COVID-19 infection at healthcare facilities and movement restrictions during the pandemic(18). The combined rates of both hypoglycaemia (15.6%) and hyperglycaemia (16.3%) demonstrate that about 1 in 3 (31.9%) participants were affected with a more frequent rate in those aged >65 years compared to <65 years (36.7% vs 30.8%). Among those experiencing the combined glycaemic complications, the need for ED care or hospital admissions were higher in the those SMBG during fasting is an important self-care practice to reduce complications and 73.8% of participants in our study reported this practice which is considerably higher than reported in prior studies.. A study in Pakistan described that only 32.6% participants performed SMBG, mostly monitoring infrequently, 1-3 times /month (20) . Similarly, the EPIDIAR study reported that 37% of T2D participants performed SMBG during Ramadan (5) . In our study, 43% participants performed SMBG daily either once, twice or thrice daily. The increasing awareness of the importance of SMBG is likely the reason for regular monitoring. A higher percentage of participants aged ≥65 years performed SMBG either at the same frequency or more often during Ramadan, compared to pre-Ramadan. This is of importance as older individuals, having longer duration of disease, higher use of insulin therapy and greater burden of co-morbidities and complications are at higher risk of blood glucose abnormalities. The development and utilisation of Ramadan-focused diabetes education programs is essential to provide better care and ensure the safety of people with diabetes who fast during Ramadan. Our study showed limited accessibility to this recommended intervention with only 43.5% participants with T2D having received education for Ramadan 2020 which is not optimal. The common source of these education sessions were mainly from doctors during routine clinic consultations. In DAR-MENA T2DM study, more than half (60.6%) of the population had access to Ramadan-focused diabetes education. The most common education format provided included diabetes educational sessions (55.3%), diabetes education programs (30.3%), and diabetes self-education (26.9%); 50.1% had access to educational material (8) . In our study, only 15% had educational leaflets as compared to 50.1% in the DAR MENA T2DM study and only 6.5% had educational sessions via apps or online. The possible reason for this pattern is probably the older age of the participants with preference for d conventional methods of education delivery. However in the era of modern and digital technology, there should be other innovative ways for delivery of Ramadan-focused diabetes education for better accessibility of information. Several limitations of this survey are the reporting of hypoglycemia which was based on symptoms rather than confirmed by SMBG. Consequently, the rates of hypoglycemia reported are possibly an overestimate as prior studies with confirmed hypoglycaemia had much lower rates of hypoglycaemia. Data were captured by the retrospective recollection of events occurring in the prior few weeks. In the absence of self-recording, events like hypoglycemia and/or hyperglycemia resulting in breaking of fast or omission of fasting in Ramadan are usually recalled clearly as the individual is required to keep count and compensate for days not fasted. Nonetheless, the lack of recording of these events limit their complete accuracy. The participation of several countries in this survey allow for reflection of fasting practices in more extensive geographical regions, however, this may introduce confounders based on the differences of the social backgrounds and the different patterns of Ramadan-related medical practice between regions. Another possible limitation is the potential bias in recruitment during COVID-19 pandemic that may impact on attendance to primary care clinics and hospitals with more stable patients possibly deferring scheduled clinic consults whereas the more vulnerable patients may avoid attendance to healthcare institutions to avoid potential exposure to COVID-19. During the COVID-19 pandemic, universally high rates of Ramadan-fasting were observed regardless of fasting risk level. Glycemic complications occurred frequently with older adults requiring higher rates of acute hospital care. Risk stratification is essential followed by pre-Ramadan interventions, Ramadan-focused diabetes education and self-monitoring to reduce and prevent complications, with particular emphasis in older adults. The Future of World Religions: Population Growth Projections International Diabetes Federation. IDF Diabetes Atlas Diabetes and Ramadan: Practical Guidelines International Diabetes Federation (IDF), in collaboration with the Diabetes and Ramadan (DAR) International Alliance Diabetes and Ramadan: Practical guidelines A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study recommendations for management of diabetes during Ramadan: update 2010 Multicountry retrospective observational study of the management and outcomes of patients with type 2 diabetes during The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study Ramadan Education Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education World Health Organisation. Nutrition Advice for Adults During the COVID-19 Outbreak Safe Ramadan practices in the context of COVID-19 The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey A survey of patients with type 2 diabetes and fasting outcomes during Ramadan 2016 in London, UK: The East London Diabetes in Ramadan Survey Predetermined Ani-Diabetic Drug Regimen Adjustments during Ramadan fasting: An Observational Study of Safety Syaidatun Nazirah Abu Zahrin. The Six Days of Voluntary Fasting in Syawal and Its Significance to the Personality of Muslims Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns -United States Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study Ramadan Fasting related Awareness, Practices and Experiences of a representative group of Urban Pakistani Diabetics Co-morbidities, n(%) Hypertension Coronary Artery Disease Chronic Kidney Disease includes abnormal eGFR or serum creatinine